Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Operating Activities:
Net income	$ 99,936	$ 64,701
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	12,803	12,304
Loss on extinguishment of debt	1,529
Deferred income tax expense	547	8,716
Share-based payments	14,196	15,978
Net pension benefit	(4,197)	(2,752)
Asset provisions	11,131	7,201
Amortization of discount on debt	8,578	8,280
Excess tax benefits from share-based payments	(7,242)
Other	770	370
Changes in assets and liabilities:
Accounts receivable	291,939	54,945
Due to consignors	(306,247)	(121,221)
Inventory	(341)	(389)
Prepaid expenses and other current assets	(8,313)	(1,602)
Other long-term assets	249	3,262
Income tax receivable and deferred income tax assets	(17,467)	(11,038)
Accrued income taxes and deferred income tax liabilities	(10,969)	10,218
Accounts payable and accrued liabilities and other liabilities	(28,013)	4,724
Net cash provided by operating activities	58,889	53,697
Investing Activities:
Funding of notes receivable	(124,016)	(156,222)
Collections of notes receivable	184,159	152,391
Capital expenditures	(12,977)	(11,597)
Distributions from equity investees	320	1,850
Increase in restricted cash	(3,621)	(8,079)
Net cash provided (used) by investing activities	43,865	(21,657)
Financing Activities:
Repayments of Convertible Notes	(22,465)
Proceeds from the settlement of Convertible Note Hedges	4,350
Dividends paid	(10,296)	(10,116)
Repayments of York Property Mortgage	(2,044)	(446)
Proceeds from exercise of employee stock options	2,566	9,980
Excess tax benefits from share-based payments	7,242
Funding of employee tax obligations upon the vesting of share-based payments	(18,575)	(6,601)
Net cash used by financing activities	(39,222)	(7,183)
Effect of exchange rate changes on cash and cash equivalents	(4,795)	(819)
Increase in cash and cash equivalents	58,737	24,038
Cash and cash equivalents at beginning of period	483,663	321,579
Cash and cash equivalents at end of period	$ 542,400	$ 345,617